ResearcherLyon 1 UniversitéNo recent work listed
Valérie Hervieu
Matched on OpenAlex author ID A5110845316. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 22
2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: none · 2019: 2 papers · 2020: 1 paper · 2021: 1 paper · 2022: none · 2023: 1 paper
Papers 6
- Necrosis as a strong independent prognostic factor required in the implementation of pathological reporting for pancreatic adenocarcinoma resection specimens. Last author DOI 10.1016/j.prp.2023.154406↗
- Management of Patients with Pancreatic Ductal Adenocarcinoma in the Real-Life Setting: Lessons from the French National Hospital Database. Co-author DOI 10.3390/cancers13143515↗
- Correction: Schwann cells support oncogenic potential of pancreatic cancer cells through TGFβ signaling. Co-author DOI 10.1038/s41419-020-2262-1↗
- Schwann cells support oncogenic potential of pancreatic cancer cells through TGFβ signaling. Co-author DOI 10.1038/s41419-019-2116-x↗
- Stromal protein βig-h3 reprogrammes tumour microenvironment in pancreatic cancer. Co-author DOI 10.1136/gutjnl-2018-317570↗
- Contrast-harmonic endoscopic ultrasound for the diagnosis of pancreatic adenocarcinoma: a prospective multicenter trial. Co-author DOI 10.1055/s-0034-1364969↗
Closest collaborators
The 22 strongest of 22 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Mustapha Adham · 4 shared papers, 2019–2023 · strength 0.44
- Paper Necrosis as a strong independent prognostic factor required in the implementation of pathological reporting for pancrea… DOI 10.1016/j.prp.2023.154406↗
- Paper Management of Patients with Pancreatic Ductal Adenocarcinoma in the Real-Life Setting: Lessons from the French National… DOI 10.3390/cancers13143515↗
- Paper Correction: Schwann cells support oncogenic potential of pancreatic cancer cells through TGFβ signaling. DOI 10.1038/s41419-020-2262-1↗
- Tanguy Fenouil · 3 shared papers, 2019–2023 · strength 0.35
- Paper Necrosis as a strong independent prognostic factor required in the implementation of pathological reporting for pancrea… DOI 10.1016/j.prp.2023.154406↗
- Paper Correction: Schwann cells support oncogenic potential of pancreatic cancer cells through TGFβ signaling. DOI 10.1038/s41419-020-2262-1↗
- Paper Schwann cells support oncogenic potential of pancreatic cancer cells through TGFβ signaling. DOI 10.1038/s41419-019-2116-x↗
- Richard Tomasini · 3 shared papers, 2019–2020 · strength 0.23
- Paper Correction: Schwann cells support oncogenic potential of pancreatic cancer cells through TGFβ signaling. DOI 10.1038/s41419-020-2262-1↗
- Paper Stromal protein βig-h3 reprogrammes tumour microenvironment in pancreatic cancer. DOI 10.1136/gutjnl-2018-317570↗
- Paper Schwann cells support oncogenic potential of pancreatic cancer cells through TGFβ signaling. DOI 10.1038/s41419-019-2116-x↗
- Christelle de la Fouchardière · 2 shared papers, 2019–2021 · strength 0.17
- Cindy Neuzillet · 2 shared papers, 2019–2020 · strength 0.15
- Élodie Roger · 2 shared papers, 2019–2020 · strength 0.15
- Victoire Cardot‐Ruffino · 2 shared papers, 2019–2020 · strength 0.15
- Laurent Bartholin · 2 shared papers, 2019–2020 · strength 0.15
- Philippe Alexandre Cassier · 2 shared papers, 2019–2020 · strength 0.15
- Andrée-Laure Herr · 1 shared paper, 2021 · strength 0.10
- Emmanuel Buc · 1 shared paper, 2021 · strength 0.10
- Nicolas Williet · 1 shared paper, 2021 · strength 0.10
- Delphine Goehrig · 1 shared paper, 2019 · strength 0.07
- Corinne Bousquet · 1 shared paper, 2019 · strength 0.07
- Paola Cappello · 1 shared paper, 2019 · strength 0.07
- Zhichong Wu · 1 shared paper, 2019 · strength 0.07
- Rémi Samain · 1 shared paper, 2019 · strength 0.07
- Jérémy Nigri · 1 shared paper, 2019 · strength 0.07
- Francesco Novelli · 1 shared paper, 2019 · strength 0.07
- Anà Hennino · 1 shared paper, 2019 · strength 0.07
- Bertrand Napoléon · 1 shared paper, 2014 · strength 0.04
- Rodica Gincul · 1 shared paper, 2014 · strength 0.04
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.